Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Cui

Showing results (291-300 of 298) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 298 results.
Nature|July 22, 2021
EGFR activation limits the response of liver cancer to lenvatinibHaojie Jin, Yaoping Shi, Yuanyuan Lv, et al.
Viruses|April 27, 2026
Next-Generation Sequencing Strategies During the 2024-2025 Avian Influenza A(H5N1) Emergency Response in the U.SJulia C Frederick, Kristine A Lacek, Matthew J Wersebe, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibilityBin Zhou, Tran Thi Nhu Thao, Donata Hoffmann, et al.
Nature|February 26, 2021
SARS-CoV-2 spike D614G change enhances replication and transmissionBin Zhou, Tran Thi Nhu Thao, Donata Hoffmann, et al.
The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Journal of Medicinal Chemistry|October 24, 2024
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for FibrosisBryce A Harrison, James E Dowling, Matthew G Bursavich, et al.
Vaccines|May 25, 2024
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron WavesHan Di, Elizabeth A Pusch, Joyce Jones, et al.
Nature Communications|July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccinesLi Wang, Markus H Kainulainen, Nannan Jiang, et al.
Pageof 30

Showing results (291-300 of 298) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 298 results.
Nature|July 22, 2021
EGFR activation limits the response of liver cancer to lenvatinibHaojie Jin, Yaoping Shi, Yuanyuan Lv, et al.
Viruses|April 27, 2026
Next-Generation Sequencing Strategies During the 2024-2025 Avian Influenza A(H5N1) Emergency Response in the U.SJulia C Frederick, Kristine A Lacek, Matthew J Wersebe, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibilityBin Zhou, Tran Thi Nhu Thao, Donata Hoffmann, et al.
Nature|February 26, 2021
SARS-CoV-2 spike D614G change enhances replication and transmissionBin Zhou, Tran Thi Nhu Thao, Donata Hoffmann, et al.
The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Journal of Medicinal Chemistry|October 24, 2024
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for FibrosisBryce A Harrison, James E Dowling, Matthew G Bursavich, et al.
Vaccines|May 25, 2024
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron WavesHan Di, Elizabeth A Pusch, Joyce Jones, et al.
Nature Communications|July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccinesLi Wang, Markus H Kainulainen, Nannan Jiang, et al.
Pageof 30